title: How to measure (or not) compliance to eradication therapy.
abstract: This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients' reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients' perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients' normal behaviour.
authors.affiliation: Centre for pharmacoepidemiology Research (CEFAR-ANF) and Faculty of Pharmacy, University of Lisbon ( Portugal ).
authors.forename: Ana Paula
authors.initials: AP
authors.lastname: Martins
authors.affiliation: Centre for pharmacoepidemiological Research (CEFAR-ANF).
authors.forename: Ana Patrícia
authors.initials: AP
authors.lastname: Ferreira
authors.affiliation: Centre for pharmacoepidemiological Research (CEFAR-ANF) and Instituto Superior de Ciências da Saúde Egas Moniz, Lisbon ( Portugal ).
authors.forename: Filipa Alves
authors.initials: FA
authors.lastname: da Costa
authors.affiliation: Faculty of Pharmacy, University of Lisbon ( Portugal ).
authors.forename: José
authors.initials: J
authors.lastname: Cabrita
keywords: Community pharmacy services; Compliance; Drug use; Health status; Helicobacter pylori; Peptic ulcer; Portugal